U.S. Physical Therapy, Inc. (USPH)

Overview News Price History Option Chain Discussions Forecast Stock Split Dividend History

U.S. Physical Therapy, Inc. stock is currently priced at $99.09, with a 24-hour trading volume of 55,948. It has seen a +1.64% increased in the last 24 hours and a -9.21% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $97.74 pivot point. If it approaches the $99.15 resistance level, significant changes may occur.

U.S. Physical Therapy, Inc. Stock (USPH) Financials Data

U.S. Physical Therapy, Inc. (USPH) Revenue 2024

USPH reported a revenue (TTM) of $604.80 million for the quarter ending December 31, 2023, a +9.34% rise year-over-year.

U.S. Physical Therapy, Inc. (USPH) Net Income 2024

USPH net income (TTM) was $14.67 million for the quarter ending December 31, 2023, a -48.19% decrease year-over-year.

U.S. Physical Therapy, Inc. (USPH) Cash Flow 2024

USPH recorded a free cash flow (TTM) of $72.68 million for the quarter ending December 31, 2023, a +44.53% increase year-over-year.

U.S. Physical Therapy, Inc. (USPH) Earnings per Share 2024

USPH earnings per share (TTM) was $2.11 for the quarter ending December 31, 2023, a -6.22% decline year-over-year.

U.S. Physical Therapy, Inc. Stock (USPH) Latest News

U.S. Physical Therapy, Inc., through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It provides workforce performance solutions, including onsite injury prevention and rehabilitation, performance optimization and ergonomic assessments for Fortune 500 companies, and other clients comprising insurers and their contractors. As of March 13, 2018, it operated 579 outpatient physical therapy clinics in 42 states; and managed 28 physical therapy facilities for unaffiliated third parties, including hospitals and physician groups. The company was founded in 1990 and is based in Houston, Texas.

Initiated	JP Morgan: Overweight	Sep-22-23
Initiated	BofA Securities: Buy	Jun-30-23
Upgrade	CJS Securities: Market Perform → Market Outperform	Dec-14-21
Reiterated	Barrington Research: Outperform	Aug-06-21
Upgrade	Barrington Research: Mkt Perform → Outperform	May-07-21
Upgrade	Jefferies: Hold → Buy	May-03-21
Downgrade	Barrington Research: Outperform → Mkt Perform	Feb-26-21
Reiterated	Barrington Research: Outperform	Jun-08-20
Downgrade	Sidoti: Buy → Neutral	Apr-30-20
Upgrade	Sidoti: Neutral → Buy	Mar-11-20
Reiterated	Barrington Research: Outperform	Feb-28-20
Upgrade	Barrington Research: Mkt Perform → Outperform	Nov-08-19
Initiated	William Blair: Outperform	Mar-08-19
Downgrade	Barrington Research: Outperform → Mkt Perform	Nov-03-17
Upgrade	Sidoti: Neutral → Buy	Sep-08-17
Upgrade	Barrington Research: Mkt Perform → Outperform	Jul-03-17
Downgrade	Barrington Research: Outperform → Mkt Perform	Mar-17-17
Upgrade	Barrington Research: Mkt Perform → Outperform	Nov-04-16
Downgrade	Barrington Research: Outperform → Mkt Perform	Aug-05-16
Upgrade	Barrington Research: Mkt Perform → Outperform	May-06-16
Downgrade	Jefferies: Buy → Hold	Mar-01-16
Downgrade	Barrington Research: Outperform → Mkt Perform	Nov-06-15
Upgrade	Barrington Research: Mkt Perform → Outperform	May-06-15
Reiterated	Dougherty & Company : Buy	Dec-12-13
Reiterated	Dougherty & Company : Buy	Aug-23-13
Reiterated	Dougherty & Company : Buy	Jan-14-13
Initiated	JMP Securities: Mkt Outperform	Jul-09-10